Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies
- PMID: 30903308
- DOI: 10.1007/s10067-019-04512-6
Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies
Abstract
Bohan and Peter is the oldest criteria for the classification of idiopathic inflammatory myopathies (IIM). Recently, 2017 EULAR/ACR criteria were introduced which were validated against a control group. The objective of this study was to assess the performance of the 2017 EULAR/ACR criteria in retrospective cohort of adult and juvenile idiopathic inflammatory myopathies and compare with Bohan and Peter criteria. This was a retrospective study of patients clinically diagnosed to have IIM in a tertiary care center in the last 10 years. Only patients with a minimum follow-up of 6 months and response to steroids and immunosuppression were included in the study. Performance of both the criteria in the cohort was assessed and compared with clinical diagnosis. Hundred and eleven patients (87 females) were included in the study. Eleven patients had juvenile onset. Ninety-three patients (83.8%) were classified as probable/definite myositis using the Bohan and Peter criteria. Eighty-nine (80.2%) patients were classified as having probable/definite inflammatory myositis using the new criteria. Agreement between the two criteria was weak in our cohort (κ-0.331). Complete details of muscle biopsy were available in 52 patients. In this subgroup, 96% were classified by Bohan and Peter and 80.8% by EULAR/ACR criteria. Bohan and Peter classified 73% and EULAR/ACR 82% of patients when biopsy was excluded (n = 111). Both criteria classified over 90% of the patients with dermatomyositis. Forty-two patients were clinically diagnosed as polymyositis, of these 32 patients had myositis overlap syndrome. Bohan and Peter classified 66.7% and EULAR/ACR classified 64.3% in this subset. Bohan and Peter criteria had high sensitivity in the presence of muscle biopsy compared with EULAR/ACR. The performance of the EULAR/ACR criteria was similar to Bohan and Peter in the absence of muscle biopsy. Both criteria had poor sensitivity in polymyositis.
Keywords: 2017 EULAR/ACR classification criteria; Bohan and Peter; Inflammatory myopathy.
Similar articles
-
Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.Korean J Intern Med. 2021 Mar;36(2):441-446. doi: 10.3904/kjim.2019.149. Epub 2019 Dec 30. Korean J Intern Med. 2021. PMID: 31875667 Free PMC article.
-
Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.Semin Arthritis Rheum. 2020 Jun;50(3):492-497. doi: 10.1016/j.semarthrit.2019.12.001. Epub 2019 Dec 28. Semin Arthritis Rheum. 2020. PMID: 32024593
-
Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients.Int J Rheum Dis. 2019 Jul;22(7):1278-1282. doi: 10.1111/1756-185X.13605. Epub 2019 May 23. Int J Rheum Dis. 2019. PMID: 31124267
-
New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.Curr Rheumatol Rep. 2018 Mar 17;20(4):18. doi: 10.1007/s11926-018-0726-4. Curr Rheumatol Rep. 2018. PMID: 29550929 Free PMC article. Review.
-
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.Clin Exp Rheumatol. 2024 Feb;42(2):403-412. doi: 10.55563/clinexprheumatol/vuc5py. Epub 2024 Feb 28. Clin Exp Rheumatol. 2024. PMID: 38436279 Review.
Cited by
-
Long Term Outcomes in Idiopathic Inflammatory Myositis: An Observational Epidemiologic Study over 15 Years.Mediterr J Rheumatol. 2023 Aug 28;34(4):513-524. doi: 10.31138/mjr.280823.lto. eCollection 2023 Dec. Mediterr J Rheumatol. 2023. PMID: 38282927 Free PMC article.
-
Polymyositis: A Case Report.Cureus. 2023 Aug 11;15(8):e43337. doi: 10.7759/cureus.43337. eCollection 2023 Aug. Cureus. 2023. PMID: 37700938 Free PMC article.
-
Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study.Biomedicines. 2022 Dec 8;10(12):3176. doi: 10.3390/biomedicines10123176. Biomedicines. 2022. PMID: 36551932 Free PMC article.
-
Clinical value of YKL-40 in patients with polymyositis/dermatomyositis: A cross-sectional study and a systematic review.J Clin Lab Anal. 2022 Sep;36(9):e24605. doi: 10.1002/jcla.24605. Epub 2022 Jul 15. J Clin Lab Anal. 2022. PMID: 35837962 Free PMC article. Review.
-
Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study.Intern Emerg Med. 2022 Oct;17(7):1921-1928. doi: 10.1007/s11739-022-03028-3. Epub 2022 Jun 26. Intern Emerg Med. 2022. PMID: 35754076 Free PMC article.
References
-
- Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:403–407 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
